Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.89 billion.
Market Cap
1.23T
Revenue
109.89B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-37.62%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.70B | 2.32% | 8,693,048 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.39B | 2.06% | 1,211,655 | 14.92B |
| 3 | ARGX | argenx SE | 55.63B | -0.17% | 400,912 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.90B | -0.61% | 1,490,595 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 38.71B | 2.19% | 9,544,011 | - |
| 6 | RPRX | Royalty Pharma plc | 32.38B | 2.82% | 6,979,030 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.12B | 1.69% | 336,791 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 26.69B | 12.59% | 14,456,655 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.51B | 0.15% | 12,406,392 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.07B | 1.36% | 873,541 | 3.23B |
| 11 | INCY | Incyte Corporation | 22.73B | 5.78% | 3,795,265 | 5.36B |
| 12 | INSM | Insmed Incorporated | 22.41B | -1.04% | 6,259,732 | 819.56M |
| 13 | ASND | Ascendis Pharma A/S | 16.20B | -0.32% | 4,450,769 | 998.25M |
| 14 | GMAB | Genmab A/S | 15.94B | -0.08% | 1,778,425 | 3.90B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.43B | 1.69% | 845,897 | 4.44B |
| 16 | EXEL | Exelixis, Inc. | 13.77B | 2.89% | 6,931,331 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.76B | 0.79% | 27,045,587 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.42B | 3.63% | 3,861,133 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.44B | 1.83% | 7,350,030 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.82B | -0.22% | 2,500,272 | 1.13B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.40B | 2.88% | 3,709,815 | 3.24B |
| 22 | CYTK | Cytokinetics, Incorporated | 11.16B | 1.72% | 7,164,189 | 105.82M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.11B | -0.48% | 18,919,765 | 622.01M |
| 24 | TECH | Bio-Techne Corporation | 11.06B | 0.42% | 12,259,237 | 1.21B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.97B | 3.42% | 1,307,858 | 417.30M |
| 26 | SMMT | Summit Therapeutics Inc. | 10.87B | -1.20% | 4,183,236 | - |
| 27 | APGE | Apogee Therapeutics, Inc. | 9.93B | -0.10% | 5,109,483 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 2,989,426 | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.37B | 3.03% | 1,590,688 | 769.10M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | -0.02% | 2,057,400 | 7.46M |
| 31 | IBRX | ImmunityBio, Inc. | 9.12B | 11.81% | 41,198,290 | 140.98M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 8.89B | -7.16% | 4,264,234 | 51.48M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 8.89B | 3.19% | 2,864,788 | 1.51B |
| 34 | PCVX | Vaxcyte, Inc. | 8.16B | 5.29% | 8,654,447 | - |
| 35 | IMVT | Immunovant, Inc. | 7.98B | 1.60% | 3,718,032 | - |
| 36 | TGTX | TG Therapeutics, Inc. | 7.91B | 4.10% | 6,852,291 | 700.35M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 7.84B | -0.61% | 2,576,434 | 74.06M |
| 38 | ABVX | ABIVAX Société Anonyme | 7.68B | 5.55% | 1,666,908 | 5.67M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 7.63B | -0.88% | 4,424,025 | - |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 7.55B | 5.53% | 3,345,793 | 569.61M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.53B | 1.46% | 2,664,138 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 7.00B | -0.09% | 3,972,905 | 827.11M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.56B | 1.80% | 7,570,477 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 6.51B | 0.24% | 9,948,148 | - |
| 45 | CGON | CG Oncology, Inc. | 6.35B | -1.21% | 4,852,036 | 5.07M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.08B | 2.59% | 1,250,945 | 274.48M |
| 47 | DFTX | Definium Therapeutics, Inc. | 5.97B | 0.36% | 12,213,409 | - |
| 48 | BLTE | Belite Bio, Inc | 5.85B | -0.73% | 255,715 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.77B | 5.21% | 8,840,002 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.55B | 0.91% | 2,828,918 | 1.14B |
| 51 | TVTX | Travere Therapeutics, Inc. | 5.47B | -0.30% | 4,896,252 | 536.20M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.46B | 4.58% | 4,733,527 | - |
| 53 | MANE | Veradermics, Incorporated | 5.30B | 6.30% | 4,047,377 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.30B | 1.74% | 3,392,848 | 4.10M |
| 55 | CAI | Caris Life Sciences, Inc. | 5.23B | -1.07% | 7,241,232 | 907.29M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 4.13% | 5,658,439 | 1.34M |
| 57 | ERAS | Erasca, Inc. | 4.98B | 7.09% | 18,334,896 | - |
| 58 | CELC | Celcuity Inc. | 4.87B | 4.19% | 2,564,924 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.55B | 4.41% | 15,421,009 | 56.99M |
| 60 | EWTX | Edgewise Therapeutics, Inc. | 4.46B | -0.55% | 2,810,739 | - |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.42B | 2.84% | 3,782,562 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.34B | 6.75% | 7,370,513 | 1.10B |
| 63 | DNLI | Denali Therapeutics Inc. | 4.06B | 3.40% | 6,526,842 | - |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.04B | 4.09% | 12,573,926 | 10.68M |
| 65 | RCUS | Arcus Biosciences, Inc. | 3.90B | 2.48% | 4,352,591 | 236.00M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 4.76% | 1,580,201 | 22.57M |
| 67 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.87B | 4.89% | 5,046,229 | 18.07M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.86B | 0.25% | 4,067,038 | 596.96M |
| 69 | PBLS | Parabilis Medicines, Inc. | 3.67B | 9.26% | 581,318 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.59B | -1.80% | 125,479 | 803.79M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.53B | 3.03% | 885,521 | - |
| 72 | ELVN | Enliven Therapeutics, Inc. | 3.50B | 1.95% | 6,711,521 | - |
| 73 | BEAM | Beam Therapeutics Inc. | 3.46B | 2.59% | 4,788,374 | 164.01M |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.46B | 1.60% | 5,436,287 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.43B | 1.24% | 3,681,143 | 225.27M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.38B | 1.16% | 3,684,215 | 415.62M |
| 77 | ALMS | Alumis Inc. | 3.37B | 5.47% | 6,164,318 | 8.40M |
| 78 | QURE | uniQure N.V. | 3.27B | -3.24% | 3,152,416 | 18.09M |
| 79 | VERA | Vera Therapeutics, Inc. | 3.05B | 4.84% | 4,151,278 | - |
| 80 | RARE | Ultragenyx Pharmaceutical Inc. | 3.02B | 5.20% | 17,178,496 | 670.00M |
| 81 | IRON | Disc Medicine, Inc. | 2.86B | 6.58% | 1,903,981 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.77B | 3.43% | 4,785,830 | 865.00K |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | -2.21% | 2,025,059 | 535.08M |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.70B | 0.82% | 7,448,116 | - |
| 85 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 0.83% | 6,901,772 | - |
| 86 | MBX | MBX Biosciences, Inc. | 2.49B | 3.85% | 2,888,470 | - |
| 87 | BHVN | Biohaven Ltd. | 2.38B | 3.19% | 9,510,155 | - |
| 88 | PHVS | Pharvaris N.V. | 2.38B | 2.13% | 504,446 | - |
| 89 | NRIX | Nurix Therapeutics, Inc. | 2.37B | 1.96% | 6,110,343 | 71.78M |
| 90 | VCEL | Vericel Corporation | 2.36B | 7.76% | 2,336,170 | 292.09M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 1.29% | 5,199,183 | - |
| 92 | NTLA | Intellia Therapeutics, Inc. | 2.33B | 4.05% | 9,823,554 | 66.09M |
| 93 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | 17.66% | 21,005,539 | - |
| 94 | IMNM | Immunome, Inc. | 2.26B | 2.89% | 4,334,646 | 4.02M |
| 95 | AGIO | Agios Pharmaceuticals, Inc. | 2.25B | 4.70% | 3,836,220 | 66.05M |
| 96 | ABCL | AbCellera Biologics Inc. | 2.25B | 10.81% | 15,607,752 | 79.21M |
| 97 | KOD | Kodiak Sciences Inc. | 2.24B | 5.43% | 2,591,122 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -1.82% | 4,497,402 | 298.30M |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.15B | 0.82% | 8,123,877 | 52.04M |
| 100 | NKTR | Nektar Therapeutics | 2.15B | 2.61% | 6,152,220 | 55.63M |
| 101 | PVLA | Palvella Therapeutics, Inc. | 2.13B | 8.82% | 1,173,443 | - |
| 102 | GENB | Generate Biomedicines, Inc. | 2.11B | 0.30% | 4,095,288 | 30.30M |
| 103 | KARD | Kardigan, Inc. | 2.11B | 4.52% | 852,340 | - |
| 104 | PGEN | Precigen, Inc. | 2.09B | 6.16% | 11,312,980 | 31.60M |
| 105 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 3.93% | 1,766,055 | 899.11M |
| 106 | ADMA | ADMA Biologics, Inc. | 2.03B | 0.34% | 5,934,317 | 509.86M |
| 107 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | 2.09% | 10,818,446 | 7.47M |
| 108 | ZLAB | Zai Lab Limited | 2.02B | -2.81% | 1,855,214 | 453.28M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.99B | 5.26% | 3,258,297 | 32.08M |
| 110 | VRDN | Viridian Therapeutics, Inc. | 1.98B | 2.93% | 5,787,325 | 70.92M |
| 111 | NUVB | Nuvation Bio Inc. | 1.97B | -2.75% | 35,528,776 | 143.05M |
| 112 | ATAI | AtaiBeckley Inc. | 1.95B | 15.50% | 63,236,992 | 3.49M |
| 113 | GHRS | GH Research PLC | 1.94B | 11.37% | 275,378 | - |
| 114 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 2.29% | 130,070 | 1.20B |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.92B | 2.96% | 1,618,925 | 20.00M |
| 116 | SION | Sionna Therapeutics, Inc. | 1.90B | -1.38% | 1,019,146 | - |
| 117 | IOVA | Iovance Biotherapeutics, Inc. | 1.90B | 0.95% | 23,715,854 | 285.61M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.04% | 4,230,021 | - |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | 7.57% | 4,567,177 | 217.17M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.88B | 2.91% | 5,919,788 | 42.95M |
| 121 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 5.39% | 42,587,971 | 66.41M |
| 122 | ABSI | Absci Corporation | 1.84B | 6.66% | 13,453,389 | 1.84M |
| 123 | ANAB | AnaptysBio, Inc. | 1.84B | 5.81% | 1,361,102 | 232.39M |
| 124 | NBTX | Nanobiotix S.A. | 1.80B | 4.53% | 111,961 | 38.27M |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 5.18% | 20,026,914 | 2.18B |
| 126 | BCAX | Bicara Therapeutics Inc. | 1.77B | 2.01% | 4,601,410 | - |
| 127 | ZYME | Zymeworks Inc. | 1.76B | 1.60% | 942,277 | 81.26M |
| 128 | INVA | Innoviva, Inc. | 1.74B | 0.94% | 2,834,672 | 420.69M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.69B | 1.52% | 7,498,597 | 65.50M |
| 130 | MESO | Mesoblast Limited | 1.69B | -9.03% | 421,646 | 65.38M |
| 131 | SEPN | Septerna, Inc. | 1.68B | 8.11% | 1,480,131 | 72.26M |
| 132 | URGN | UroGen Pharma Ltd. | 1.68B | 0.47% | 1,348,411 | 140.49M |
| 133 | FTRE | Fortrea Holdings Inc. | 1.67B | -0.34% | 3,629,665 | 2.71B |
| 134 | ZBIO | Zenas BioPharma, Inc. | 1.63B | 4.86% | 3,500,463 | 10.00M |
| 135 | AKTS | Aktis Oncology, Inc. | 1.63B | -5.49% | 1,230,578 | 8.28M |
| 136 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | 1.63% | 6,471,079 | 204.73M |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.58B | 0.50% | 1,956,585 | - |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.57B | 5.22% | 3,545,014 | 20.00M |
| 139 | IMCR | Immunocore Holdings plc | 1.57B | 1.11% | 509,937 | 412.81M |
| 140 | DMRA | Damora Therapeutics, Inc. | 1.56B | 12.36% | 8,623,755 | - |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.53B | -13.03% | 5,489,471 | 11.13M |
| 142 | COAG | Hemab Therapeutics Holdings, Inc. | 1.51B | 16.77% | 329,158 | - |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.51B | 4.13% | 1,708,666 | - |
| 144 | SVRA | Savara Inc. | 1.50B | -2.16% | 6,158,830 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.46B | -0.45% | 1,678,523 | - |
| 146 | NVAX | Novavax, Inc. | 1.46B | 3.74% | 8,409,598 | 596.34M |
| 147 | AAPG | Ascentage Pharma Group International | 1.43B | -1.94% | 195,417 | 82.08M |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.39B | -0.52% | 619,791 | 1.30M |
| 149 | ARDX | Ardelyx, Inc. | 1.37B | -8.42% | 17,524,272 | 427.68M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.36B | 5.97% | 2,402,478 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.31B | 0.87% | 2,664,341 | - |
| 152 | IMTX | Immatics N.V. | 1.30B | - | 228,260 | 43.00M |
| 153 | MNKD | MannKind Corporation | 1.28B | 5.34% | 11,867,914 | 360.78M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 10.54% | 194,404 | - |
| 155 | EYPT | EyePoint, Inc. | 1.15B | -0.36% | 3,554,606 | 7.61M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | 3.37% | 3,430,292 | - |
| 157 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.13B | 11.35% | 39,463,853 | 69.64M |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -0.43% | 2,725,239 | - |
| 159 | WVE | Wave Life Sciences Ltd. | 1.12B | 1.39% | 6,686,690 | 71.80M |
| 160 | MGTX | MeiraGTx Holdings plc | 1.12B | 5.03% | 4,775,428 | 79.76M |
| 161 | XNCR | Xencor, Inc. | 1.12B | 2.10% | 1,981,661 | 97.36M |
| 162 | SANA | Sana Biotechnology, Inc. | 1.03B | 4.91% | 10,365,248 | - |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 994.89M | -0.35% | 5,541,136 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 986.52M | 0.74% | 3,762,474 | - |
| 165 | DRTS | Alpha Tau Medical Ltd. | 981.12M | -2.60% | 491,703 | - |
| 166 | DBVT | DBV Technologies S.A. | 969.96M | -0.06% | 208,757 | 5.74M |
| 167 | KURA | Kura Oncology, Inc. | 967.64M | 5.21% | 5,273,147 | 71.64M |
| 168 | REPL | Replimune Group, Inc. | 960.32M | 4.49% | 9,987,454 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 956.69M | 1.11% | 8,576,580 | 59.00K |
| 170 | ANRO | Alto Neuroscience, Inc. | 948.94M | 6.88% | 4,414,918 | - |
| 171 | PHAR | Pharming Group N.V. | 939.20M | 0.53% | 3,484 | 369.49M |
| 172 | LBRX | LB Pharmaceuticals Inc | 915.36M | 2.97% | 1,413,689 | - |
| 173 | SLDB | Solid Biosciences Inc. | 914.60M | 4.85% | 6,144,832 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 911.11M | 2.47% | 3,701,995 | 13.73M |
| 175 | TBPH | Theravance Biopharma, Inc. | 908.88M | 1.38% | 1,311,425 | 109.78M |
| 176 | EVMN | Evommune, Inc. | 906.94M | 4.35% | 1,402,427 | 10.00M |
| 177 | ABUS | Arbutus Biopharma Corporation | 904.72M | 3.85% | 6,802,402 | 191.45M |
| 178 | ANNX | Annexon, Inc. | 897.86M | 6.41% | 14,806,929 | - |
| 179 | VOR | Vor Biopharma Inc. | 872.39M | 7.84% | 8,125,892 | - |
| 180 | ODTX | Odyssey Therapeutics, Inc. | 864.68M | 1.85% | 252,771 | 1.06M |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 851.49M | 3.68% | 2,661,449 | 204.89M |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 848.05M | 6.48% | 5,015,465 | 98.99M |
| 183 | GERN | Geron Corporation | 846.81M | -3.65% | 36,634,082 | 196.12M |
| 184 | DSGN | Design Therapeutics, Inc. | 833.80M | -0.67% | 2,909,250 | - |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 799.24M | 2.19% | 2,878,207 | 122.29M |
| 186 | AURA | Aura Biosciences, Inc. | 772.10M | 2.04% | 1,627,479 | - |
| 187 | IVA | Inventiva S.A. | 772.09M | -2.57% | 1,335,150 | 7.94M |
| 188 | CLYM | Climb Bio, Inc. | 748.97M | 3.32% | 6,319,935 | - |
| 189 | CTMX | CytomX Therapeutics, Inc. | 740.19M | 3.98% | 28,894,577 | 35.54M |
| 190 | ALLO | Allogene Therapeutics, Inc. | 735.18M | 3.40% | 25,919,232 | 22.00K |
| 191 | OCS | Oculis Holding AG | 724.66M | 2.21% | 374,879 | 1.40M |
| 192 | NVCT | Nuvectis Pharma, Inc. | 721.23M | -2.44% | 1,277,557 | - |
| 193 | CADL | Candel Therapeutics, Inc. | 717.32M | 3.38% | 4,925,638 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 715.85M | 4.60% | 885,139 | 299.77M |
| 195 | IMMX | Immix Biopharma, Inc. | 710.48M | 2.67% | 7,137,068 | - |
| 196 | SGP | SpyGlass Pharma, Inc. | 708.12M | 12.60% | 1,477,583 | - |
| 197 | RLMD | Relmada Therapeutics, Inc. | 701.72M | 3.72% | 15,605,163 | - |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 698.32M | 1.83% | 8,838,853 | 8.37M |
| 199 | TENX | Tenax Therapeutics, Inc. | 686.67M | 4.27% | 5,207,904 | - |
| 200 | AGMB | AgomAb Therapeutics NV | 680.11M | 2.23% | 96,414 | - |
| 201 | DNA | Ginkgo Bioworks Holdings, Inc. | 669.58M | 7.11% | 2,529,097 | 151.40M |
| 202 | OMER | Omeros Corporation | 627.49M | -19.12% | 10,918,913 | 9.89M |
| 203 | EIKN | Eikon Therapeutics, Inc. | 619.89M | 16.24% | 3,172,877 | - |
| 204 | DRUG | Bright Minds Biosciences Inc. | 619.56M | 3.38% | 365,163 | - |
| 205 | PRME | Prime Medicine, Inc. | 619.52M | 7.86% | 7,659,139 | 4.03M |
| 206 | ACHV | Achieve Life Sciences, Inc. | 618.01M | 5.61% | 12,441,203 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 616.73M | 9.24% | 3,051,990 | 11.88M |
| 208 | CRMD | CorMedix Inc. | 615.85M | 1.68% | 4,576,823 | 400.05M |
| 209 | FDMT | 4D Molecular Therapeutics, Inc. | 606.40M | 0.69% | 2,021,419 | 88.24M |
| 210 | SLBT | SL Science Holding Limited | 606.09M | -10.50% | 115,022 | - |
| 211 | TECX | Tectonic Therapeutic, Inc. | 603.63M | 3.09% | 307,183 | - |
| 212 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 592.79M | -3.77% | 715,985 | - |
| 213 | FTH | Faeth Therapeutics, Inc. | 589.56M | -7.30% | 145,911 | - |
| 214 | MNPR | Monopar Therapeutics Inc. | 587.35M | 0.06% | 310,266 | - |
| 215 | MDXG | MiMedx Group, Inc. | 585.36M | 3.15% | 5,633,333 | 389.42M |
| 216 | GYRE | Gyre Therapeutics, Inc. | 574.73M | 0.96% | 854,111 | 117.05M |
| 217 | TRAX | First Tracks Biotherapeutics, Inc. | 559.32M | -2.08% | 1,731,941 | - |
| 218 | PROK | ProKidney Corp. | 552.77M | 7.65% | 9,463,457 | 889.00K |
| 219 | ALT | Altimmune, Inc. | 548.42M | -1.74% | 17,105,420 | 36.00K |
| 220 | RGNX | REGENXBIO Inc. | 541.79M | 2.34% | 4,356,421 | 87.82M |
| 221 | CTNM | Contineum Therapeutics, Inc. | 530.51M | 6.21% | 3,888,531 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 529.91M | 10.22% | 1,589,332 | 71.10M |
| 223 | XOMA | XOMA Royalty Corporation | 528.60M | -0.12% | 439,305 | 48.56M |
| 224 | RZLT | Rezolute, Inc. | 526.51M | 0.20% | 6,577,264 | - |
| 225 | PRTA | Prothena Corporation plc | 524.58M | 8.09% | 1,914,358 | 57.94M |
| 226 | ARVN | Arvinas, Inc. | 516.17M | -0.37% | 3,028,565 | 89.40M |
| 227 | FBRX | Forte Biosciences, Inc. | 513.88M | 12.40% | 3,079,361 | - |
| 228 | KYTX | Kyverna Therapeutics, Inc. | 513.11M | 2.93% | 6,756,608 | - |
| 229 | ZURA | Zura Bio Limited | 508.24M | 17.84% | 9,625,489 | - |
| 230 | OCGN | Ocugen, Inc. | 507.78M | 9.49% | 57,047,121 | 4.47M |
| 231 | NGNE | Neurogene Inc. | 506.13M | 5.33% | 504,969 | 925.00K |
| 232 | STRO | Sutro Biopharma, Inc. | 505.73M | 3.28% | 2,773,522 | 99.61M |
| 233 | CABA | Cabaletta Bio, Inc. | 495.69M | 4.11% | 24,302,947 | - |
| 234 | STTK | Shattuck Labs, Inc. | 493.82M | 8.97% | 12,486,826 | 1.00M |
| 235 | VALN | Valneva SE | 482.77M | -0.38% | 27,493 | 180.25M |
| 236 | SLN | Silence Therapeutics plc | 478.95M | 1.40% | 1,080,782 | 839.00K |
| 237 | OVID | Ovid Therapeutics Inc. | 475.93M | 5.37% | 22,546,117 | 7.12M |
| 238 | CCCC | C4 Therapeutics, Inc. | 471.02M | -3.18% | 20,144,336 | 34.86M |
| 239 | ARTV | Artiva Biotherapeutics, Inc. | 467.42M | 8.95% | 1,040,439 | 251.00K |
| 240 | EDIT | Editas Medicine, Inc. | 437.37M | 4.01% | 6,394,377 | 38.69M |
| 241 | SGMT | Sagimet Biosciences Inc. | 435.97M | 2.92% | 8,602,404 | - |
| 242 | VTVT | vTv Therapeutics Inc. | 435.33M | -5.08% | 94,153 | 36.84M |
| 243 | PRLD | Prelude Therapeutics Incorporated | 434.40M | 6.83% | 3,693,041 | 16.72M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 431.88M | 2.89% | 794,007 | - |
| 245 | AUTL | Autolus Therapeutics plc | 428.49M | 1.26% | 771,841 | 92.62M |
| 246 | BNTC | Benitec Biopharma Inc. | 424.96M | -4.85% | 1,022,243 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 418.42M | 0.87% | 16,994,881 | 109.16M |
| 248 | PBYI | Puma Biotechnology, Inc. | 412.79M | 5.74% | 1,103,492 | 227.18M |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 407.10M | 4.09% | 938,044 | 69.21M |
| 250 | HELP | Cybin Inc. | 401.66M | 7.64% | 2,935,055 | - |
| 251 | ANL | Adlai Nortye Ltd. | 400.00M | -1.57% | 299,515 | 5.00M |
| 252 | INDP | Indaptus Therapeutics, Inc. | 386.16M | 4.60% | 138,087 | - |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 382.80M | 4.45% | 1,123,310 | 51.00M |
| 254 | LRMR | Larimar Therapeutics, Inc. | 382.04M | 4.57% | 9,106,785 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 379.17M | 0.75% | 10,479,698 | 9.01M |
| 256 | CMPX | Compass Therapeutics, Inc. | 374.58M | 0.48% | 7,606,102 | 850.00K |
| 257 | LXEO | Lexeo Therapeutics, Inc. | 372.98M | 1.06% | 2,339,082 | - |
| 258 | UPB | Upstream Bio, Inc. | 367.33M | 6.13% | 1,311,180 | 3.32M |
| 259 | OABI | OmniAb, Inc. | 365.33M | 0.40% | 2,069,730 | 28.94M |
| 260 | VNDA | Vanda Pharmaceuticals Inc. | 361.41M | 2.74% | 1,526,276 | 217.78M |
| 261 | AVIR | Atea Pharmaceuticals, Inc. | 359.32M | 3.10% | 1,245,884 | - |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 354.88M | 0.31% | 7,672,788 | - |
| 263 | DMAC | DiaMedica Therapeutics Inc. | 352.94M | 6.50% | 962,878 | - |
| 264 | VSTM | Verastem, Inc. | 332.16M | 9.57% | 8,027,814 | 49.59M |
| 265 | GALT | Galectin Therapeutics Inc. | 328.63M | 17.97% | 6,475,738 | - |
| 266 | PALI | Palisade Bio, Inc. | 328.07M | 5.00% | 23,230,633 | - |
| 267 | IRD | Opus Genetics, Inc. | 325.58M | 7.53% | 7,866,281 | 11.98M |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 325.51M | 2.14% | 3,820,334 | 1.00 |
| 269 | ABEO | Abeona Therapeutics Inc. | 319.74M | 0.90% | 2,924,913 | 14.54M |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 319.10M | 4.92% | 22,539,712 | 14.78M |
| 271 | IMRX | Immuneering Corporation | 307.96M | 5.08% | 8,407,499 | - |
| 272 | MGNX | MacroGenics, Inc. | 305.74M | 3.22% | 8,516,839 | 157.08M |
| 273 | NMRA | Neumora Therapeutics, Inc. | 303.87M | 8.61% | 14,976,320 | - |
| 274 | CNXU | Conexeu Sciences Inc. | 293.27M | 7.24% | 36,652 | - |
| 275 | SRZN | Surrozen, Inc. | 292.81M | 2.85% | 1,003,236 | 7.49M |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 292.20M | 3.56% | 6,115,792 | - |
| 277 | GLSI | Greenwich LifeSciences, Inc. | 290.63M | 8.02% | 298,750 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 290.56M | -1.81% | 5,650,980 | 114.70K |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 287.59M | 6.60% | 7,490,415 | 26.87M |
| 280 | BCYC | Bicycle Therapeutics plc | 286.23M | 2.24% | 843,322 | 63.50M |
| 281 | IFRX | InflaRx N.V. | 282.80M | 3.23% | 1,345,300 | 33.82K |
| 282 | TRDA | Entrada Therapeutics, Inc. | 278.90M | 8.25% | 1,448,055 | 5.74M |
| 283 | ADAG | Adagene Inc. | 276.84M | 2.18% | 461,685 | 7.67M |
| 284 | RNAC | Cartesian Therapeutics, Inc. | 276.77M | 5.49% | 765,474 | 1.78M |
| 285 | ALXO | ALX Oncology Holdings Inc. | 274.51M | 13.97% | 14,472,414 | - |
| 286 | NAGE | Niagen Bioscience, Inc. | 272.95M | 3.32% | 2,372,839 | 130.42M |
| 287 | ARMP | Armata Pharmaceuticals, Inc. | 271.66M | 13.85% | 1,561,283 | 5.20M |
| 288 | LYEL | Lyell Immunopharma, Inc. | 270.91M | -7.05% | 1,698,407 | 31.00K |
| 289 | IVVD | Invivyd, Inc. | 262.70M | 1.47% | 27,612,235 | 55.87M |
| 290 | NAUT | Nautilus Biotechnology, Inc. | 254.16M | -11.89% | 7,704,178 | - |
| 291 | ACIU | AC Immune SA | 253.95M | 4.49% | 259,239 | 4.62M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 253.89M | 8.72% | 5,421,172 | 32.72M |
| 293 | FULC | Fulcrum Therapeutics, Inc. | 253.21M | 5.26% | 4,934,392 | 80.00M |
| 294 | FHTX | Foghorn Therapeutics Inc. | 247.77M | 4.71% | 1,225,302 | 28.22M |
| 295 | FATE | Fate Therapeutics, Inc. | 244.77M | 12.30% | 15,315,504 | 6.32M |
| 296 | AVXL | Anavex Life Sciences Corp. | 242.80M | 6.29% | 4,198,556 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 240.27M | 1.14% | 28,550 | 18.47M |
| 298 | TARA | Protara Therapeutics, Inc. | 231.56M | 3.00% | 1,617,322 | - |
| 299 | KPTI | Karyopharm Therapeutics Inc. | 231.39M | 7.93% | 3,221,417 | 151.12M |
| 300 | CHRS | Coherus Oncology, Inc. | 231.37M | 1.35% | 4,460,508 | 46.88M |
| 301 | RNA | Atrium Therapeutics, Inc. | 225.62M | 3.21% | 758,666 | 36.68M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 223.74M | 1.22% | 3,961,815 | 7.15M |
| 303 | QTTB | Q32 Bio Inc. | 223.32M | 10.21% | 493,958 | 53.74M |
| 304 | CAMP | Camp4 Therapeutics Corporation | 218.09M | 7.14% | 3,406,293 | 3.93M |
| 305 | KROS | Keros Therapeutics, Inc. | 217.51M | 5.57% | 1,433,696 | 33.18M |
| 306 | CDXS | Codexis, Inc. | 217.24M | 6.22% | 2,386,588 | 78.09M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 216.91M | 1.13% | 2,305,183 | 36.49M |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 210.74M | 10.35% | 1,608,875 | 17.56M |
| 309 | IMUX | Immunic, Inc. | 208.41M | 1.53% | 234,493 | - |
| 310 | CNTN | Canton Strategic Holdings, Inc. | 207.32M | 10.61% | 6,157,306 | - |
| 311 | OTLK | Outlook Therapeutics, Inc. | 206.68M | 6.21% | 11,491,945 | 333.14K |
| 312 | ALEC | Alector, Inc. | 206.51M | 0.54% | 3,845,447 | 18.42M |
| 313 | TTRX | Turn Therapeutics Inc. | 206.43M | 1.61% | 113,189 | - |
| 314 | NERV | Minerva Neurosciences, Inc. | 203.59M | 6.33% | 3,867,655 | - |
| 315 | CLLS | Cellectis S.A. | 202.87M | -2.08% | 8,477 | 75.11M |
| 316 | NKTX | Nkarta, Inc. | 202.47M | 1.80% | 1,373,103 | - |
| 317 | NGEN | NervGen Pharma Corp. | 198.60M | -2.09% | 1,080,742 | - |
| 318 | CGEN | Compugen Ltd. | 197.68M | 3.47% | 292,512 | 72.66M |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 195.55M | 0.88% | 1,055,620 | 54.71M |
| 320 | MDWD | MediWound Ltd. | 195.23M | 4.46% | 313,548 | 14.48M |
| 321 | EQ | Equillium, Inc. | 192.84M | 3.39% | 417,614 | 4.39M |
| 322 | ORMP | Oramed Pharmaceuticals Inc. | 191.12M | -6.60% | 4,231,360 | 2.00M |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 190.37M | -13.15% | 7,420,398 | - |
| 324 | NBP | NovaBridge Biosciences | 189.66M | 2.50% | 172,015 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 188.10M | 8.00% | 3,340,776 | 45.07M |
| 326 | ANTX | AN2 Therapeutics, Inc. | 187.28M | 1.17% | 3,646,247 | - |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 185.31M | 3.60% | 2,544,165 | 76.38M |
| 328 | KRRO | Korro Bio, Inc. | 183.17M | 4.35% | 788,707 | 3.84M |
| 329 | LENZ | LENZ Therapeutics, Inc. | 182.48M | 5.63% | 1,860,866 | 20.99M |
| 330 | OKUR | OnKure Therapeutics, Inc. | 181.78M | 6.64% | 2,961,959 | - |
| 331 | PYXS | Pyxis Oncology, Inc. | 175.49M | 24.22% | 6,884,203 | 13.86M |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 170.46M | 6.79% | 5,570,947 | - |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 168.70M | -0.80% | 915,050 | 1.78M |
| 334 | IPHA | Innate Pharma S.A. | 168.65M | 1.24% | 10,306 | 10.57M |
| 335 | CRBU | Caribou Biosciences, Inc. | 166.62M | 7.01% | 13,887,977 | 11.20M |
| 336 | YDES | YD Bio Limited | 165.25M | -2.89% | 16,676 | 510.36K |
| 337 | KZIA | Kazia Therapeutics Limited | 162.49M | 4.17% | 90,086 | 1.27M |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 161.93M | 5.94% | 2,411,505 | - |
| 339 | PRQR | ProQR Therapeutics N.V. | 161.20M | -2.24% | 2,048,864 | 15.73M |
| 340 | HUMA | Humacyte, Inc. | 157.32M | 14.29% | 46,984,321 | 2.02M |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 155.70M | 1.06% | 1,209,501 | 225.00K |
| 342 | TLSA | Tiziana Life Sciences Ltd | 152.58M | 5.75% | 216,136 | - |
| 343 | SPRB | Spruce Biosciences, Inc. | 151.68M | 4.43% | 423,348 | 697.00K |
| 344 | MOLN | Molecular Partners AG | 147.59M | -3.31% | 11,323 | 856.30K |
| 345 | ACOG | Alpha Cognition Inc. | 141.53M | 2.54% | 189,331 | 10.83M |
| 346 | MENS | Jyong Biotech Ltd. | 139.56M | -1.05% | 161,062 | - |
| 347 | CNTB | Connect Biopharma Holdings Limited | 137.89M | 5.80% | 2,489,259 | 233.00K |
| 348 | HURA | TuHURA Biosciences, Inc. | 137.55M | -16.60% | 4,511,860 | - |
| 349 | ENLV | Enlivex Ltd. | 137.40M | -1.81% | 218,227 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 135.01M | 4.78% | 943,260 | 2.29M |
| 351 | SPRO | Spero Therapeutics, Inc. | 130.86M | 11.88% | 2,222,022 | 61.19M |
| 352 | ADCT | ADC Therapeutics SA | 129.73M | -1.92% | 4,447,685 | 79.18M |
| 353 | COYA | Coya Therapeutics, Inc. | 129.01M | 7.21% | 249,386 | 7.94M |
| 354 | GNLX | Genelux Corporation | 127.45M | -1.03% | 353,835 | 8.00K |
| 355 | AGEN | Agenus Inc. | 126.18M | 5.21% | 5,006,304 | 123.87M |
| 356 | GUTS | Fractyl Health, Inc. | 117.88M | -7.00% | 1,526,195 | 3.00K |
| 357 | PEPG | PepGen Inc. | 117.59M | -0.58% | 512,149 | - |
| 358 | VRCA | Verrica Pharmaceuticals Inc. | 117.50M | 10.14% | 113,859 | 37.16M |
| 359 | ENGN | enGene Therapeutics Inc. | 117.23M | -1.13% | 1,242,338 | - |
| 360 | NTHI | NeOnc Technologies Holdings, Inc. | 115.95M | 1.33% | 72,104 | 39.99K |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 113.62M | 3.90% | 100,096 | - |
| 362 | ONCY | Oncolytics Biotech Inc. | 113.12M | 2.99% | 777,054 | - |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 110.39M | 1.67% | 6,078,829 | - |
| 364 | AARD | Aardvark Therapeutics, Inc. | 104.50M | -5.34% | 1,664,840 | - |
| 365 | CBUS | Cibus, Inc. | 103.81M | 0.37% | 279,731 | 4.29M |
| 366 | VANI | Vivani Medical, Inc. | 103.48M | 5.26% | 164,555 | - |
| 367 | KLRS | Kalaris Therapeutics, Inc. | 102.78M | 0.47% | 164,530 | - |
| 368 | CUE | Cue Biopharma, Inc. | 102.72M | -0.59% | 82,524 | 32.73M |
| 369 | PTHS | Pelthos Therapeutics Inc. | 100.90M | -0.62% | 19,552 | 27.70M |
| 370 | ALPS | Alps Group Inc | 100.84M | -6.77% | 92,088 | 3.74M |
| 371 | CGTX | Cognition Therapeutics, Inc. | 100.24M | -0.88% | 3,492,545 | - |
| 372 | BDTX | Black Diamond Therapeutics, Inc. | 97.99M | 0.59% | 8,578,830 | 70.00M |
| 373 | BMEA | Biomea Fusion, Inc. | 95.44M | 7.32% | 1,349,446 | - |
| 374 | ANIX | Anixa Biosciences, Inc. | 94.92M | 6.49% | 1,041,902 | - |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 94.70M | 1.66% | 45,295 | 23.14M |
| 376 | PMN | ProMIS Neurosciences, Inc. | 94.43M | 3.12% | 4,073 | - |
| 377 | CSBR | Champions Oncology, Inc. | 92.07M | 9.05% | 15,479 | 57.95M |
| 378 | FBIO | Fortress Biotech, Inc. | 91.68M | -8.61% | 1,103,740 | 66.16M |
| 379 | SEER | Seer, Inc. | 91.27M | -4.05% | 438,858 | 15.17M |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 91.17M | -0.86% | 830,349 | 3.17M |
| 381 | PYPD | PolyPid Ltd. | 91.08M | 3.94% | 150,344 | - |
| 382 | INO | Inovio Pharmaceuticals, Inc. | 90.50M | 1.85% | 1,194,902 | 65.34K |
| 383 | RNTX | Rein Therapeutics Inc. | 90.36M | 3.83% | 331,059 | - |
| 384 | NRXS | NeurAxis, Inc. | 90.03M | 5.21% | 104,409 | 4.28M |
| 385 | LIXT | Lixte Biotechnology Holdings, Inc. | 89.03M | 8.12% | 213,993 | - |
| 386 | ICCC | ImmuCell Corporation | 88.57M | -1.01% | 26,893 | 29.93M |
| 387 | LONA | LeonaBio, Inc. | 88.30M | 8.17% | 60,717 | - |
| 388 | ACET | Adicet Bio, Inc. | 87.89M | 5.95% | 95,745 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 85.73M | 4.44% | 379,887 | - |
| 390 | CRDF | Cardiff Oncology, Inc. | 85.46M | 3.31% | 6,851,421 | 525.00K |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | 0.81% | 53,471 | - |
| 392 | RLYB | Rallybio Corporation | 84.77M | 1.85% | 92,844 | 858.00K |
| 393 | ATHE | Alterity Therapeutics Limited | 84.10M | -1.63% | 23,412 | 4.43M |
| 394 | OSTX | OS Therapies Incorporated | 83.73M | 4.44% | 647,653 | - |
| 395 | IBIO | iBio, Inc. | 82.96M | 5.03% | 1,512,777 | 300.00K |
| 396 | HRTX | Heron Therapeutics, Inc. | 81.39M | 4.88% | 6,428,234 | 150.71M |
| 397 | OKYO | OKYO Pharma Limited | 81.34M | 0.65% | 47,252 | - |
| 398 | ENTX | Entera Bio Ltd. | 80.24M | 12.41% | 417,560 | 42.00K |
| 399 | HYFT | MindWalk Holdings Corp. | 78.47M | 3.95% | 393,160 | 20.70M |
| 400 | GOSS | Gossamer Bio, Inc. | 76.75M | -4.96% | 38,552,917 | 55.54M |
| 401 | ELTX | Elicio Therapeutics, Inc. | 76.29M | 6.67% | 2,188,552 | - |
| 402 | GANX | Gain Therapeutics, Inc. | 74.64M | 1.74% | 550,488 | - |
| 403 | ANVS | Annovis Bio, Inc. | 73.17M | 4.24% | 1,364,405 | - |
| 404 | EDSA | Edesa Biotech, Inc. | 72.83M | 9.64% | 67,888 | - |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 71.91M | 6.33% | 274,324 | - |
| 406 | XBIT | XBiotech Inc. | 71.04M | -0.43% | 74,205 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 70.05M | 0.88% | 321,031 | - |
| 408 | BYSI | BeyondSpring Inc. | 69.49M | 4.37% | 51,628 | 1.88M |
| 409 | MCRB | Seres Therapeutics, Inc. | 68.56M | 3.07% | 301,442 | 1.15M |
| 410 | EXOZ | eXoZymes, Inc. | 68.09M | 7.16% | 5,587 | -700.00 |
| 411 | IMA | ImageneBio, Inc. | 67.90M | -0.34% | 17,247 | 800.00K |
| 412 | CING | Cingulate Inc. | 65.85M | 4.20% | 334,668 | - |
| 413 | MNOV | MediciNova, Inc. | 64.97M | 0.76% | 114,374 | 596.64K |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 63.46M | 3.48% | 178,033 | - |
| 415 | TCRX | TScan Therapeutics, Inc. | 63.31M | 15.33% | 713,271 | 9.14M |
| 416 | VRXA | Veraxa Biotech AG | 58.50M | -1.28% | 219,219 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 57.99M | 2.92% | 34,438 | - |
| 418 | FLNA | Filana Therapeutics, Inc. | 57.97M | 3.45% | 358,556 | - |
| 419 | BOLD | Boundless Bio, Inc. | 57.50M | 1.99% | 238,210 | - |
| 420 | DWTX | Dogwood Therapeutics, Inc. | 55.49M | 11.49% | 205,631 | - |
| 421 | XLO | Xilio Therapeutics, Inc. | 54.14M | -0.45% | 43,911 | 53.48M |
| 422 | CNTX | Context Therapeutics Inc. | 53.29M | 3.57% | 14,816,437 | - |
| 423 | ATYR | aTyr Pharma, Inc. | 51.72M | -5.75% | 12,153,126 | 190.00K |
| 424 | IBO | Impact BioMedical Inc. | 50.78M | -1.05% | 27,350 | 39.00K |
| 425 | TIL | Instil Bio, Inc. | 50.39M | -0.40% | 19,561 | - |
| 426 | PDSB | PDS Biotechnology Corporation | 49.59M | -0.62% | 632,135 | - |
| 427 | LTRN | Lantern Pharma Inc. | 49.25M | 5.18% | 147,149 | - |
| 428 | IMMP | Immutep Limited | 48.84M | -4.50% | 319,719 | 5.28M |
| 429 | ELOX | Eloxx Pharmaceuticals, Inc. | 48.62M | 2.51% | 28,345 | - |
| 430 | VERU | Veru Inc. | 48.31M | 2.38% | 253,394 | 16.89M |
| 431 | MREO | Mereo BioPharma Group plc | 47.34M | -1.46% | 2,959,245 | 500.00K |
| 432 | CRVO | CervoMed Inc. | 47.21M | 4.18% | 382,613 | 2.09M |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 47.06M | 4.62% | 208,645 | 22.33M |
| 434 | KALA | KALA BIO, Inc. | 46.85M | -1.18% | 31,830 | - |
| 435 | RADX | Radiopharm Theranostics Limited | 46.50M | -7.16% | 60,464 | 10.86M |
| 436 | HYPD | Hyperion DeFi, Inc. | 46.38M | 3.38% | 667,813 | 1.04M |
| 437 | APLM | Apollomics, Inc. | 45.68M | -5.45% | 32,400 | 8.84M |
| 438 | GNTA | Genenta Science S.p.A. | 42.70M | 4.62% | 162,036 | - |
| 439 | RNXT | RenovoRx, Inc. | 42.56M | 1.47% | 524,816 | 1.49M |
| 440 | ESLA | Estrella Immunopharma, Inc. | 42.29M | 3.45% | 42,088 | - |
| 441 | ACTU | Actuate Therapeutics, Inc. | 40.20M | -14.29% | 846,205 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 38.73M | 0.42% | 269,627 | - |
| 443 | ABVC | ABVC BioPharma, Inc. | 38.66M | 5.52% | 216,667 | 797.92K |
| 444 | INMB | INmune Bio Inc. | 37.75M | -4.70% | 3,400,322 | 50.00K |
| 445 | NTRB | Nutriband Inc. | 37.20M | 0.99% | 21,503 | 1.80M |
| 446 | ALGS | Aligos Therapeutics, Inc. | 34.47M | 1.27% | 54,392 | 4.71M |
| 447 | SNTI | Senti Biosciences Holdings, Inc. | 33.95M | 1.87% | 185,401 | 38.00K |
| 448 | DARE | Daré Bioscience, Inc. | 31.31M | 4.50% | 109,833 | 1.16M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 31.06M | 4.21% | 126,337 | 90.00K |
| 450 | LSTA | Lisata Therapeutics, Inc. | 30.60M | -0.29% | 20,708 | 170.00K |
| 451 | LITS | Lite Strategy, Inc. | 30.55M | 9.89% | 354,358 | - |
| 452 | NNVC | NanoViricides, Inc. | 30.53M | 3.08% | 184,722 | - |
| 453 | GRDX | GridAI Technologies Corp. | 29.34M | 1.85% | 98,775 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 29.31M | -26.62% | 83,615 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 29.31M | 4.39% | 17,730 | 7.44M |
| 456 | DYAI | Dyadic International, Inc. | 29.19M | 8.10% | 395,386 | 3.81M |
| 457 | PSTV | Plus Therapeutics, Inc. | 28.91M | -1.41% | 286,056 | 5.18M |
| 458 | VTGN | Vistagen Therapeutics, Inc. | 28.80M | 13.85% | 1,462,647 | 1.27M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 28.59M | -2.64% | 6,869 | 14.97M |
| 460 | SER | Serina Therapeutics, Inc. | 27.15M | -0.55% | 77,006 | 130.00K |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 26.77M | -0.21% | 55,150 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 26.67M | 3.03% | 96,368 | - |
| 463 | IGC | IGC Pharma, Inc. | 26.32M | 0.42% | 419,973 | 1.11M |
| 464 | EVAX | Evaxion A/S | 25.77M | -1.59% | 38,860 | 7.53M |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 24.70M | 5.06% | 238,228 | -13.27K |
| 466 | QNTM | Quantum BioPharma Ltd. | 24.17M | -3.31% | 104,247 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 23.89M | -4.02% | 149,077 | - |
| 468 | LGVN | Longeveron Inc. | 22.29M | -1.85% | 304,021 | 1.22M |
| 469 | MRKR | Marker Therapeutics, Inc. | 21.93M | 0.38% | 67,019 | 3.55M |
| 470 | PLUR | Pluri Inc. | 21.92M | -5.96% | 19,238 | 1.08M |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.62M | -0.52% | 120,321 | 454.00K |
| 472 | PLRZ | Polyrizon Ltd. | 21.49M | 0.70% | 4,195 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 20.68M | 2.36% | 121,343 | 345.00K |
| 474 | NCEL | NewcelX Ltd. | 20.46M | 7.04% | 11,814 | - |
| 475 | LPCN | Lipocine Inc. | 20.28M | 3.36% | 19,388 | 2.00M |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.14M | 2.02% | 11,269 | - |
| 477 | PTN | Palatin Technologies, Inc. | 19.66M | 11.61% | 28,837 | 12.88M |
| 478 | CVM | CEL-SCI Corporation | 19.40M | 13.92% | 330,709 | - |
| 479 | AEON | AEON Biopharma, Inc. | 18.99M | 4.62% | 27,954 | - |
| 480 | KTTA | Pasithea Therapeutics Corp. | 18.16M | 0.33% | 232,040 | - |
| 481 | CELU | Celularity Inc. | 17.95M | -6.81% | 222,078 | 26.55M |
| 482 | MBRX | Moleculin Biotech, Inc. | 17.45M | 9.36% | 1,296,277 | - |
| 483 | ATOS | Atossa Therapeutics, Inc. | 16.19M | 6.21% | 377,706 | - |
| 484 | TPST | Tempest Therapeutics, Inc. | 15.99M | 2.86% | 140,389 | - |
| 485 | MLEC | Moolec Science SA | 15.81M | -1.04% | 9,042 | 7.83M |
| 486 | HOWL | Werewolf Therapeutics, Inc. | 15.70M | -3.29% | 690,704 | 1.14M |
| 487 | GTBP | GT Biopharma, Inc. | 15.51M | 3.34% | 843,048 | - |
| 488 | QNCX | Quince Therapeutics, Inc. | 15.38M | -3.34% | 323,100 | - |
| 489 | XCUR | Exicure, Inc. | 15.30M | -4.76% | 68,961 | 500.00K |
| 490 | HIND | Vyome Holdings, Inc. | 15.16M | 2.37% | 18,093 | 152.72K |
| 491 | PASG | Passage Bio, Inc. | 15.08M | 8.55% | 280,491 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 14.82M | -0.94% | 122,894 | 5.61M |
| 493 | BIVI | BioVie Inc. | 14.63M | 8.99% | 66,442 | - |
| 494 | LNAI | Lunai Bioworks Inc. | 14.55M | -9.83% | 150,305 | 20.94K |
| 495 | CYCN | Cyclerion Therapeutics, Inc. | 14.34M | 6.62% | 27,907 | 1.99M |
| 496 | TVRD | Tvardi Therapeutics, Inc. | 14.07M | -36.44% | 1,997,891 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 14.06M | 0.99% | 67,846 | 225.00K |
| 498 | BCDA | BioCardia, Inc. | 13.65M | 10.09% | 1,470,432 | 3.00K |
| 499 | INAB | IN8bio, Inc. | 13.39M | - | 49,704 | - |
| 500 | LEXX | Lexaria Bioscience Corp. | 13.14M | -3.11% | 46,392 | 368.00K |